These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34344008)

  • 41. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center.
    Vogl TJ; Trapp M; Schroeder H; Mack M; Schuster A; Schmitt J; Neuhaus P; Felix R
    Radiology; 2000 Feb; 214(2):349-57. PubMed ID: 10671580
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.
    Brown DB; Pilgram TK; Darcy MD; Fundakowski CE; Lisker-Melman M; Chapman WC; Crippin JS
    J Vasc Interv Radiol; 2005 Dec; 16(12):1661-6. PubMed ID: 16371533
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Accumulation of lipiodol in hepatocellular carcinoma after transarterial chemoembolization with 5 FU-lipiodol-emulsion].
    Okada K; Tada I; Suzuki K; Kim YI; Kobayashi M
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2557-61. PubMed ID: 2843123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma.
    Suzuki M; Suzuki H; Yamamoto T; Mamada Y; Mizuno H; Tominaga T; Suga M; Suemori S; Kato Y; Sato A; Yamanouchi E; Sakuyama K; Maeyama S; Shinagawa T; Okabe K
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the relationship between hepatocellular carcinoma location and transarterial chemoembolization efficacy.
    Miki I; Murata S; Uchiyama F; Yasui D; Ueda T; Sugihara F; Saito H; Yamaguchi H; Murakami R; Kawamoto C; Uchida E; Kumita SI
    World J Gastroenterol; 2017 Sep; 23(35):6437-6447. PubMed ID: 29085193
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Arterial embolization of massive hepatocellular carcinoma with lipiodol and gelatin sponge.
    Xie LL; Sun CJ; Li XD; Wang YH; Wang CE
    Indian J Cancer; 2015 Feb; 51 Suppl 2():e49-51. PubMed ID: 25712844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Switching the loaded agent from epirubicin to cisplatin: salvage transcatheter arterial chemoembolization with drug-eluting microspheres for unresectable hepatocellular carcinoma.
    Seki A; Hori S
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):555-62. PubMed ID: 21562932
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease.
    Fidelman N; Kerlan RK
    AJR Am J Roentgenol; 2015 Oct; 205(4):742-52. PubMed ID: 26397322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transarterial embolization for large hepatocellular carcinoma with use of superabsorbent polymer microspheres: initial experience.
    Osuga K; Khankan AA; Hori S; Okada A; Sugiura T; Maeda M; Nagano H; Yamada A; Murakami T; Nakamura H
    J Vasc Interv Radiol; 2002 Sep; 13(9 Pt 1):929-34. PubMed ID: 12354828
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantification of Blood Pressure Changes in the Vascular Compartment When Using an Anti-Reflux Catheter during Chemoembolization versus Radioembolization: A Retrospective Case Series.
    Rose SC; Narsinh KH; Newton IG
    J Vasc Interv Radiol; 2017 Jan; 28(1):103-110. PubMed ID: 27840042
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
    Abdel-Rahman OM; Elsayed Z
    Cochrane Database Syst Rev; 2016 Feb; 2():CD011313. PubMed ID: 26905230
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An investigation of efficacy, safety, and prognostic factors of drug-eluting beads-transarterial chemoembolization operation with CalliSpheres
    Zhang X; Lin X; Qiu H; Peng Z
    J Clin Lab Anal; 2019 Oct; 33(8):e22975. PubMed ID: 31328832
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transarterial chemoembolization for unresectable hepatocellular carcinoma: A comparison of the efficacy and safety of 2 embolic agents.
    Chen S; Yu W; Zhang K; Liu W; Chen Q
    Medicine (Baltimore); 2018 May; 97(21):e10832. PubMed ID: 29794774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Transarterial chemoembolization (TAE) with degradable starch microspheres (DSM) in advanced hepatocellular carcinoma].
    Horikiri N; Yamakado K; Nakatsuka A; Ishii T; Matsushima N; Tanaka N; Takeda K
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1493-6. PubMed ID: 11707962
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retiform Purpura as a Complication of Microsphere Emboli Following Transarterial Chemoembolization for Primary Hepatocellular Carcinoma: A Case Report and Literature Review.
    Kuan A; Khoo L; Yang SS; Chia HY; Lee JSS
    Am J Dermatopathol; 2020 Jul; 42(7):e108-e110. PubMed ID: 31809275
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
    Liu YS; Lin CY; Chuang MT; Lin CY; Tsai YS; Wang CK; Ou MC
    BMC Gastroenterol; 2018 Aug; 18(1):124. PubMed ID: 30075752
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transarterial Chemoembolization of HCC with Radiopaque Microspheres: Evaluation with Computed Tomography and the Complementary Role of Contrast-Enhanced Ultrasonography.
    Moschouris H; Malagari K; Dimakis A; Kiakidis T; Anagnostopoulou A
    Cardiovasc Intervent Radiol; 2020 Jul; 43(7):1075-1083. PubMed ID: 32394087
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advances in endovascular therapy to treat primary hepatocellular carcinoma.
    Guo Z; Yu H; Liu C; Si T; Yang X; Zhang W; Xu Y; Li Y
    Drug Discov Ther; 2015 Oct; 9(5):342-51. PubMed ID: 26632543
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatocellular carcinoma supplied by the right lumbar artery.
    Miyayama S; Yamashiro M; Okuda M; Yoshie Y; Sugimori N; Igarashi S; Nakashima Y; Matsui O
    Cardiovasc Intervent Radiol; 2010 Feb; 33(1):53-60. PubMed ID: 19484293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Large-sized hepatocellular carcinoma (HCC): a neoadjuvant treatment protocol with repetitive transarterial chemoembolization (TACE) before percutaneous MR-guided laser-induced thermotherapy (LITT).
    Zangos S; Eichler K; Balzer JO; Straub R; Hammerstingl R; Herzog C; Lehnert T; Heller M; Thalhammer A; Mack MG; Vogl TJ
    Eur Radiol; 2007 Feb; 17(2):553-63. PubMed ID: 16896704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.